{
"id":"mk19_b_pm_s9",
"subspecialtyId":"pm",
"title":"High-Altitude–Related Illnesses",
"jsonContent":{
"type":"section",
"id":"mk19_b_pm_s9",
"title":{
"__html":"High-Altitude–Related Illnesses"
},
"titleNode":{
"type":"section-title",
"hlId":"b3cc18",
"children":[
"High-Altitude–Related Illnesses"
]
},
"children":[
{
"type":"section",
"id":"mk19_b_pm_s9_1",
"title":{
"__html":"Pathogenesis of High-Altitude Illness"
},
"titleNode":{
"type":"section-title",
"hlId":"46fbda",
"children":[
"Pathogenesis of High-Altitude Illness"
]
},
"children":[
{
"type":"p",
"hlId":"5ce112",
"children":[
"Diminishing barometric pressure associated with an ascent to altitude reduces the amount of ambient oxygen available for gas exchange, a condition known as hypobaric hypoxia. Physiologic responses to hypobaric hypoxia mechanistically underlie many disorders collectively referred to as high-altitude illness ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t40",
"wrapId":"1",
"children":[
"Table 40"
]
}
]
},
")"
]
},
". Susceptibility to high-altitude illness is individualized and difficult to predict. Although high-altitude illnesses can occur at all ages regardless of fitness level, patients with a history of high-altitude–related illness are at risk for recurrence. Other risk factors include rapid ascent (more than 3500 m in less than 2 days or more than 500 m per day above altitudes of 3000 m) and medical comorbidities that impair oxygenation, such as interstitial lung disease, COPD, and pulmonary hypertension. Acetazolamide and gradual ascent to altitude can be used prophylactically in patients who have previously suffered high-altitude illness or have other risk factors."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_b_pm_t40"
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"b8f605",
"hvc":true,
"children":[
"Acetazolamide and gradual ascent to altitude can be used prophylactically in patients who have previously suffered high-altitude illness or have other risk factors."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s9_2",
"title":{
"__html":"Acute Mountain Sickness"
},
"titleNode":{
"type":"section-title",
"hlId":"f0389f",
"children":[
"Acute Mountain Sickness"
]
},
"children":[
{
"type":"p",
"hlId":"3a284d",
"children":[
"Cerebral blood flow and oxygen delivery to the brain are altered by the hypoxia and hypocapnia associated with the ascent to altitude. In acute mountain sickness—the most common high-altitude illness—symptoms are nonspecific and include headache, fatigue, nausea, and vomiting; disturbed sleep related to high-altitude periodic breathing is also common. Cerebral autoregulatory mechanisms can dampen the stress on blood flow, resulting in mild symptoms. Acute mountain sickness is estimated to affect as many as 25% of visitors to an altitude of 2000 m, the elevation at most major western U.S. ski areas. Heavy exertion and dehydration tend to amplify symptoms, which, provided there is no further ascent, typically resolve within 24 to 48 hours. Treatment and prevention approaches are shown in ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t40",
"wrapId":"2",
"children":[
"Table 40"
]
}
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_b_pm_t40"
]
},
{
"type":"p",
"hlId":"bf19e0",
"children":[
"In high-altitude periodic breathing, chemoreceptors that are sensitive to hypoxia increase ventilation. This drives arterial P",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"CO"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" toward the apneic threshold and results in a pause in breathing (central apnea) when the threshold is crossed. With this pause, arterial P",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"CO"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"2"
]
}
]
},
" eventually rises sufficiently to again stimulate breathing. The cycle of ventilatory overshoot, hypocapnia, and central apneas repeats at night. Patients complain of interrupted sleep and insomnia and may experience paroxysms of dyspnea that awaken them. Alcohol ingestion, which promotes dehydration, can intensify the sequelae of high-altitude periodic breathing."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"e9375d",
"children":[
"Symptoms of acute mountain sickness are nonspecific and include headache, fatigue, nausea, and vomiting; disturbed sleep related to high-altitude periodic breathing is common."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s9_3",
"title":{
"__html":"High-Altitude Cerebral Edema"
},
"titleNode":{
"type":"section-title",
"hlId":"72c145",
"children":[
"High-Altitude Cerebral Edema"
]
},
"children":[
{
"type":"p",
"hlId":"67cd2c",
"children":[
"When the cerebral compensatory pathways are overwhelmed, severe, life-threatening cerebral edema can ensue. High-altitude cerebral edema is a feared manifestation of acute mountain sickness that tends to occur at higher elevations (above 3000 m). Recognition of cerebral edema mandates immediate intervention. Definitive treatment is immediate descent from altitude, particularly when the patient is still ambulatory, because incapacitation at high altitude exponentially complicates evacuation."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"d9fd68",
"children":[
"Definitive treatment of high-altitude cerebral edema is immediate descent from altitude, particularly when the patient is still ambulatory, because incapacitation at high altitude exponentially complicates evacuation."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s9_4",
"title":{
"__html":"High-Altitude Pulmonary Edema"
},
"titleNode":{
"type":"section-title",
"hlId":"eaf1c4",
"children":[
"High-Altitude Pulmonary Edema"
]
},
"children":[
{
"type":"p",
"hlId":"21607a",
"children":[
"The pulmonary vasculature constricts in response to hypoxia, resulting in increases in pulmonary vascular resistance. An exaggerated increase in pulmonary artery pressure is associated with high-altitude pulmonary edema. High-altitude pulmonary edema is uncommon but can be life-threatening. Patients are often tachypneic and tachycardic, and crackles or wheezing can be heard on chest examination. Pink, frothy sputum or frank hemoptysis may occur, which heralds worsening gas exchange and respiratory failure. The treatment of choice is supplemental oxygen along with rest, both of which will acutely reduce pulmonary artery pressures. Descent from altitude should be considered. See ",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t40",
"wrapId":"3",
"children":[
"Table 40"
]
}
]
},
" for other adjunctive therapies."
]
},
{
"type":"inline-wrap",
"wrapId":"3",
"contentIds":[
"mk19_b_pm_t40"
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s9_5",
"title":{
"__html":"Air Travel in Pulmonary Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"b2e281",
"children":[
"Air Travel in Pulmonary Disease"
]
},
"children":[
{
"type":"p",
"hlId":"5d4f99",
"children":[
"The principles of hypobaric hypoxia also apply to commercial airline travel. Cabins are pressurized to the equivalent of 1500 to 2500 m (approximately 5000-8000 ft) in altitude, resulting in an inspired oxygen tension between 110 and 120 mm Hg (about 70% of the levels encountered at sea level). The resultant arterial P",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"O"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" of approximately 60 mm Hg (8.0 kPa) is adequate for healthy individuals, but those with underlying pulmonary disease are at risk for significant hypoxemia during flight ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t41",
"wrapId":"4",
"children":[
"Table 41"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"4",
"contentIds":[
"mk19_b_pm_t41"
]
},
{
"type":"p",
"hlId":"5df076",
"children":[
"The risk for pneumothorax in air travel is low, as airline cabins are pressurized. In patients with chronic lung disease (such as asthma or COPD), signs or symptoms indicative of a pneumothorax (acute chest pain, dyspnea) should prompt the in-flight administration of supplemental oxygen, which promotes resorption of pleural air. For patients with chronic lung disease associated with hypoxia, preflight evaluation to determine recommended oxygen use is helpful ",
{
"type":"tag",
"tagName":"span",
"attrs":{
"className":"text-nowrap"
},
"children":[
"(",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
{
"type":"table-link",
"target":"mk19_b_pm_t42",
"wrapId":"5",
"children":[
"Table 42"
]
}
]
},
")"
]
},
"."
]
},
{
"type":"inline-wrap",
"wrapId":"5",
"contentIds":[
"mk19_b_pm_t42"
]
},
{
"type":"p",
"hlId":"7a9096",
"children":[
"After cardiothoracic surgery, a delay of 3 to 4 weeks before air travel is reasonable. An existing pneumothorax has traditionally been considered a contraindication to flight because of the potential risk for expansion and tension physiology. Air travel may be safe in the presence of a small postoperative pneumothorax that has been radiographically stable."
]
},
{
"type":"keypoints",
"children":[
{
"type":"keypoint",
"hlId":"06aa8f",
"children":[
"Pulse oximetry is a useful screening tool for patients who have chronic lung disease, with which an oxyhemoglobin saturation of less than 92% at sea level indicates a likely need for in-flight supplemental oxygen."
]
},
{
"type":"keypoint",
"hlId":"9d01d9",
"hvc":true,
"children":[
"During air travel, doubling the flow rate is typically adequate for patients who are already receiving long-term supplemental oxygen."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_b_pm_s9_6",
"bibliography":true,
"title":{
"__html":"Bibliography"
},
"titleNode":{
"type":"section-title",
"hlId":"a7cc81",
"children":[
"Bibliography"
]
},
"children":[
{
"type":"references",
"children":[
{
"type":"reference",
"children":[
"Ahmedzai S, Balfour-Lynn IM, Bewick T, et al; British Thoracic Society Standards of Care Committee. Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax. 2011;66 Suppl 1:i1-30. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/21856702",
"target":"_blank"
},
"children":[
"PMID: 21856702"
]
},
" doi:10.1136/thoraxjnl-2011-200295"
]
},
{
"type":"reference",
"children":[
"Bärtsch P, Swenson ER. Clinical practice: acute high-altitude illnesses. N Engl J Med. 2013;368:2294-302. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/23758234",
"target":"_blank"
},
"children":[
"PMID: 23758234"
]
},
" doi:10.1056/NEJMcp1214870"
]
},
{
"type":"reference",
"children":[
"Ergan B, Akgun M, Pacilli AMG, et al. Should I stay or should I go? COPD and air travel. Eur Respir Rev. 2018;27. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29898904",
"target":"_blank"
},
"children":[
"PMID: 29898904"
]
},
" doi:10.1183/16000617.0030-2018"
]
},
{
"type":"reference",
"children":[
"Hu X, Cowl CT, Baqir M, et al. Air travel and pneumothorax. Chest. 2014;145:688-694. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/24687705",
"target":"_blank"
},
"children":[
"PMID: 24687705"
]
},
" doi:10.1378/chest.13-2363"
]
},
{
"type":"reference",
"children":[
"Luks AM, Auerbach PS, Freer L, et al. Wilderness Medical Society clinical practice guidelines for the prevention and treatment of acute altitude illness: 2019 update. Wilderness Environ Med. 2019;30:S3-S18. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/31248818",
"target":"_blank"
},
"children":[
"PMID: 31248818"
]
},
" doi:10.1016/j.wem.2019.04.006"
]
},
{
"type":"reference",
"children":[
"Luks AM, Swenson ER, Bärtsch P. Acute high-altitude sickness. Eur Respir Rev. 2017;26. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28143879",
"target":"_blank"
},
"children":[
"PMID: 28143879"
]
},
" doi:10.1183/16000617.0096-2016"
]
},
{
"type":"reference",
"children":[
"Meier D, Collet TH, Locatelli I, et al. Does this patient have acute mountain sickness?: the Rational Clinical Examination systematic review. JAMA. 2017;318:1810-1819. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/29136449",
"target":"_blank"
},
"children":[
"PMID: 29136449"
]
},
" doi:10.1001/jama.2017.16192"
]
},
{
"type":"reference",
"children":[
"Nicholson TT, Sznajder JI. Fitness to fly in patients with lung disease. Ann Am Thorac Soc. 2014;11:1614-22. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/25393882",
"target":"_blank"
},
"children":[
"PMID: 25393882"
]
},
" doi:10.1513/AnnalsATS.201406-234PS"
]
},
{
"type":"reference",
"children":[
"West JB. Physiological effects of chronic hypoxia. N Engl J Med. 2017;376:1965-1971. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/28514605",
"target":"_blank"
},
"children":[
"PMID: 28514605"
]
},
" doi:10.1056/NEJMra1612008"
]
}
]
}
]
}
]
},
"tablesContent":{
"mk19_b_pm_t40":{
"id":"mk19_b_pm_t40",
"number":40,
"bookId":"pm",
"title":{
"__html":"Spectrum of High-Altitude Illness Syndromes"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"80cf79",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 40. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t40"
}
]
},
"Spectrum of High-Altitude Illness Syndromes"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"37d463",
"class":"col hd l",
"children":[
"High-Altitude Illness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6cfd63",
"class":"col hd l",
"children":[
"Elevation Level"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"dd2968",
"class":"col hd l",
"children":[
"Symptoms"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4c4ac0",
"class":"col hd l",
"children":[
"Treatment"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c53b76",
"class":"col hd l",
"children":[
"Prevention"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4f3514",
"class":"cell txt l",
"children":[
"Acute mountain sickness"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"fa037b",
"class":"cell txt l",
"children":[
"2000-2500 m"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1bd688",
"class":"cell txt l",
"children":[
"Nonspecific; include headache, malaise, anorexia, nausea, vomiting"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"9d6b28",
"class":"cell txt l",
"children":[
"Oxygen, acetazolamide, dexamethasone, descent from altitude, aspirin or NSAID for headache"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d0d989",
"class":"cell txt l",
"children":[
"Gradual ascent (<500 m/d) at high altitude; prophylaxis with acetazolamide or dexamethasone in rapid ascent or patients at high risk"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1ca6ee",
"class":"cell txt l",
"children":[
"High-altitude cerebral edema"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"82a633",
"class":"cell txt l",
"children":[
"3000-4000 m"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"61322d",
"class":"cell txt l",
"children":[
"Confusion, irritability, ataxic gait, coma, death"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"264a74",
"class":"cell txt l",
"children":[
"Descent from altitude, supplemental oxygen, hyperbaric therapy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"64a8ec",
"class":"cell txt l",
"children":[
"Gradual ascent; consider acetazolamide or dexamethasone in patients at high risk"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a49b64",
"class":"cell txt l",
"children":[
"High-altitude pulmonary edema"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"783c59",
"class":"cell txt l",
"children":[
">2500 m"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a7b1c2",
"class":"cell txt l",
"children":[
"Cough, exertional intolerance, dyspnea at rest"
]
},
" ",
{
"type":"p",
"hlId":"f046ab",
"class":"cell txt l",
"children":[
"(2-4 d after arrival at new altitude)"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"cb6a42",
"class":"cell txt l",
"children":[
"Supplemental oxygen and descent from altitude; adjunctive therapy: nifedipine, PDE-5 inhibitors"
]
},
" ",
{
"type":"p",
"hlId":"a238c8",
"class":"cell txt l",
"children":[
"Diuretics and nitrates not recommended"
]
},
" ",
{
"type":"p",
"hlId":"2c2771",
"class":"cell txt l",
"children":[
"Intubation may be required"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6bbea8",
"class":"cell txt l",
"children":[
"Gradual ascent; consider nifedipine in patients at high risk"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
"PDE-5 = phosphodiesterase-5."
]
]
},
"mk19_b_pm_t41":{
"id":"mk19_b_pm_t41",
"number":41,
"bookId":"pm",
"title":{
"__html":"Risk Factors for Air Travel in Pulmonary Disease"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"7dc319",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 41. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t41"
}
]
},
"Risk Factors for Air Travel in Pulmonary Disease"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8a7945",
"class":"col hd l",
"children":[
"Risk Factor"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"4f6f24",
"class":"cell txt l",
"children":[
"Advanced COPD complicated by hypercapnic respiratory failure"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"f361bb",
"class":"cell txt l",
"children":[
"Pulmonary hypertension"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"550cf3",
"class":"cell txt l",
"children":[
"Restrictive lung disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"45c92f",
"class":"cell txt l",
"children":[
"Recent exacerbation of chronic lung disease"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6e4690",
"class":"cell txt l",
"children":[
"History of previous in-flight symptoms"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
},
"mk19_b_pm_t42":{
"id":"mk19_b_pm_t42",
"number":42,
"bookId":"pm",
"title":{
"__html":"Preflight Screening in Chronic Lung Disease"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"02aff3",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
"className":"table-number"
},
"children":[
{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Table 42. "
]
},
{
"type":"new-window-link",
"targetType":"table",
"targetId":"mk19_b_pm_t42"
}
]
},
"Preflight Screening in Chronic Lung Disease"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"39c30c",
"class":"col hd l",
"children":[
"Oxygen Saturation",
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
}
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c76e38",
"class":"col hd l",
"children":[
"Recommendation"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ada697",
"class":"cell txt l",
"children":[
"<92%"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"26fbf3",
"class":"cell txt l",
"children":[
"In-flight oxygen (typically 2-3 L/min)"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"98e251",
"class":"cell txt l",
"children":[
"92%-95%"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a317c3",
"class":"cell txt l",
"children":[
"Hypoxia altitude simulation testing"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"a4185e",
"class":"cell txt l",
"children":[
"Already receiving long-term oxygen"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e56b48",
"class":"cell txt l",
"children":[
"Double flow rate during flight"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[
[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"By pulse oximetry at sea level."
]
]
}
}
}